secwatch.observer — SEC 8-K summary
======================================

Issuer:     Nemaura Medical Inc. (—)
CIK:        0001602078
Form:       8-K
Filed at:   2024-05-17T23:59:59+00:00
Accession:  0001079973-24-000772
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Shareholders approve reverse stock split authorization at ratio of 1:10 to 1:150
--------------------------------------------------------------------------------

- Approved by written consent on May 9, 2024; board to determine final ratio.
- Fractional shares resulting from reverse split will be rounded up to nearest whole share.
- No other matters were submitted to a vote of security holders.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1602078/000107997324000772/0001079973-24-000772-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1602078/000107997324000772/nmra_8k.htm
  HTML page:      https://secwatch.observer/filing/0001079973-24-000772

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer